New study aims to spot which kids with rare brain inflammation will recover fully

NCT ID NCT07188194

Not yet recruiting Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will follow 32 children diagnosed with their first episode of acute disseminated encephalomyelitis (ADEM), a rare brain inflammation that usually follows an infection. Researchers will check if early MRI scans, spinal fluid tests, and symptoms can predict which children will recover fully and which might develop lasting problems or other conditions like multiple sclerosis. The goal is to better understand the disease and improve care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify which children with ADEM need more aggressive treatment early on, potentially improving recovery.
What could go wrong: This is a small, early observational study (32 participants) that only looks for patterns—it does not test any treatment. Results may not apply to all children with ADEM.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE DISSEMINATED ENCEPHALOMYELITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute disseminated encephalomyelitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE DISSEMINATED ENCEPHALOMYELITIS

More trials for these conditions

Other studies related to the condition(s) this trial covers.